The SLC39A14-PIWIL2 fusion identified in this study follows this mechanism, with the SLC39A14 promoter driving PIWIL2 overexpression, amplifying its tumor-promoting potential in HCC. Here, PIWIL2 is linked to hepatocellular carcinoma.